Loading...

Home
ETF
DARE

DARE

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

DARE News

Daré (DARE) Q4 2025 Earnings Call Transcript

May 21 2026NASDAQ.COM

Daré Bioscience Initiates Phase 2 Clinical Trial for DARE-HPV

May 18 2026Newsfilter

Daré Bioscience Q1 2026 Earnings Call Insights

May 15 2026seekingalpha

Dare Bioscience Q1 Earnings Exceed Expectations

May 14 2026seekingalpha

Dare Bioscience Set to Announce Q1 Earnings

May 13 2026seekingalpha

Daré Bioscience Q4 2025 Earnings Call Insights

Mar 26 2026seekingalpha

Dare Bioscience Reports Strong FY Earnings Beat

Mar 26 2026seekingalpha

Dare Bioscience Reports FY EPS Beat

Mar 26 2026seekingalpha

Dare Bioscience to Announce FY Earnings Results

Mar 25 2026seekingalpha

Daré Bioscience Receives FDA Clearance for HPV Treatment Study

Feb 23 2026Newsfilter

Atossa Therapeutics Receives FDA Orphan Drug Designation, Stock Rises Nearly 13%

Jan 20 2026NASDAQ.COM

Daré Bioscience Launches DARE to PLAY™ Sildenafil Cream for Women, Effective in 10-15 Minutes

Dec 10 2025Globenewswire

Daré Bioscience Launches DARE to PLAY™ Sildenafil Cream for Women, Effective in 10-15 Minutes

Dec 10 2025Newsfilter

Daré Bioscience Regains Ovaprene® Rights, Advancing Women's Health Innovation

Dec 01 2025Newsfilter

Daré Bioscience (DARE) Third Quarter 2025 Earnings Call Transcript

Nov 14 2025NASDAQ.COM

Daré Bioscience Set to Receive Up to $300,000 for Global Assessment of Contraceptive Innovation Capabilities

Nov 03 2025Newsfilter